| Not Yet Recruiting | Safety Study of CZ10 in Healthy Volunteers NCT06708767 | Nextrast, Inc. | Phase 1 |
| Not Yet Recruiting | The Role of NaV1.8 in Human Pain Models NCT07511400 | Medical University of Vienna | EARLY_Phase 1 |
| Recruiting | The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response NCT06983730 | Beth Israel Deaconess Medical Center | EARLY_Phase 1 |
| Completed | Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG) NCT07272889 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | A Multi-domain Intervention for Healthy Aging NCT06767410 | University of Bari | N/A |
| Recruiting | Near-InfraRed Spectroscopy of Auricular Stimulation NCT06825364 | University of Pittsburgh | N/A |
| Recruiting | Muscle Vibration as a Countermeasure Against Hypoactivity-induced NCT07021079 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Recruiting | An Investigation to Evaluate Wearing Properties of Three Different Investigational Devices NCT07034014 | Molnlycke Health Care AB | N/A |
| Not Yet Recruiting | Stomach Processing and Emptying Evaluation With Diet and Ultrasound NCT06988397 | Medical University of Warsaw | N/A |
| Completed | Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir NCT07007806 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation NCT06945614 | General Biophysics LLC | Phase 1 |
| Recruiting | Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal NCT06911320 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin NCT06921941 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations NCT06959888 | Aligos Therapeutics | Phase 1 |
| Not Yet Recruiting | Measurement of the Optic Nerve Diameter in Different Healthcare Operators NCT06830460 | University Magna Graecia | N/A |
| Completed | A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects NCT06636500 | Cullgen Australia Pty Ltd | Phase 1 |
| Completed | Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function NCT06608433 | University Hospital, Basel, Switzerland | N/A |
| Recruiting | Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone NCT07314346 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Phase 1 BIO 300 Oral Suspension NCT06741345 | Humanetics Corporation | Phase 1 |
| Completed | A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in He NCT06757738 | Traws Pharma, Inc. | Phase 1 |
| Completed | Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir NCT06356194 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | A Clinical Study of AK0610 NCT06996704 | Shanghai Ark Biopharmaceutical Co., Ltd. | Phase 1 |
| Completed | Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usabilit NCT07099612 | University Medical Center Groningen | N/A |
| Completed | Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimi NCT06050291 | NewAmsterdam Pharma | Phase 1 |
| Completed | Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir NCT06204679 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers NCT06141889 | BioAge Labs, Inc. | Phase 1 |
| Completed | Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744. NCT06118385 | BenevolentAI Bio | Phase 1 |
| Completed | Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects NCT05881993 | Comanche Biopharma | EARLY_Phase 1 |
| Completed | The Study of Bemnifosbuvir in Healthy Japanese Subjects NCT05905497 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects NCT05905484 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects NCT05672667 | Wake Forest University Health Sciences | Phase 1 |
| Completed | Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir NCT05731843 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain NCT05179421 | Wake Forest University Health Sciences | Phase 2 |
| Completed | A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers NCT04901078 | Kinoxis Therapeutics Pty Ltd | Phase 1 |
| Completed | Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal NCT05256732 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998) NCT05154123 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998) NCT05004415 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Bronchopulmonary PK of AT-527 (R07496998) NCT04877769 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Drug-drug Interaction Study of Midazolam and AT-527 (R07496998) NCT04865445 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998) NCT04849299 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 NCT04784000 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Compo NCT04836572 | SQ Innovation, Inc. | N/A |
| Completed | Study of AT-527 in Healthy Subjects (R07496998) NCT04711187 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal F NCT04242953 | Sun Pharma Advanced Research Company Limited | Phase 1 |
| Completed | Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Ra NCT03777488 | London School of Hygiene and Tropical Medicine | Phase 1 |
| Completed | Effect of Charcoal on Gastrointestinal Absorption of Tiotropium NCT03945344 | Orion Corporation, Orion Pharma | Phase 1 |
| Completed | A Study of AST-008 in Healthy Subjects NCT03086278 | Exicure, Inc. | Phase 1 |
| Completed | Glasdegib Absolute Bioavailability Study NCT03270878 | Pfizer | Phase 1 |
| Completed | Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers NCT03031535 | Dauntless Pharmaceuticals | Phase 1 |
| Completed | Ibuprofen Suspension Bioequivalence Study NCT02503085 | Reckitt Benckiser Healthcare (UK) Limited | Phase 1 |
| Completed | Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers NCT02393950 | Orion Corporation, Orion Pharma | Phase 1 |
| Completed | A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects NCT02256423 | Simbec Research | Phase 1 |
| Terminated | Efficacy of Spinal Oxytocin in Healthy Volunteers NCT01996605 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Ibuprofen and Paracetamol Pharmacokinetic Study NCT02452450 | Reckitt Benckiser Healthcare (UK) Limited | Phase 1 |
| Completed | A Study of LY2140023 in Healthy Participants NCT01609218 | Denovo Biopharma LLC | Phase 1 |
| Completed | Phase I Pharmacokinetic Study (SALBLOCK) NCT01564199 | Orion Corporation, Orion Pharma | Phase 1 |
| Completed | Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers NCT01425450 | Trident Pharmaceuticals Inc | Phase 1 |
| Completed | AZD8566 Food Effect/Microtracer Study NCT00866385 | AstraZeneca | Phase 1 |